Carbetapentane and guaifenesin and Ibritumomab Intravenous
Determining the interaction of Carbetapentane and guaifenesin and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / guaifenesin
Brand name: Allfen C, Allfen CX, Xpect-AT, BetaVent, Oratuss, Pulmari-GP, Certuss, Dynex VR, Carba-XP, AMBI 1000/5, Duratuss CS, Respi-Tann G, Allres-G, Tusso-ZR, Tusso-ZMR, exall, Expectuss
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbetapentane and guaifenesin-Ibritumomab Tiuxetan
- Carbetapentane and guaifenesin-Ibrutinib
- Carbetapentane and guaifenesin-Ibrutinib Capsules
- Carbetapentane and guaifenesin-Ibrutinib Tablets
- Carbetapentane and guaifenesin-Ibu
- Carbetapentane and guaifenesin-IBU Tablets
- Ibritumomab Intravenous-Carbetapentane and pseudoephedrine
- Ibritumomab Intravenous-Carbidopa
- Ibritumomab Intravenous-Carbidopa and levodopa
- Ibritumomab Intravenous-Carbidopa and levodopa enteral
- Ibritumomab Intravenous-Carbidopa and Levodopa Enteral Suspension
- Ibritumomab Intravenous-Carbidopa and Levodopa Extended-Release Capsules